Talanx AG (LON:0QA8)
106.75
+0.84 (0.79%)
At close: Nov 5, 2025
Talanx AG Revenue
Talanx AG had revenue of 12.01B EUR in the quarter ending June 30, 2025, with 35.97% growth. This brings the company's revenue in the last twelve months to 45.27B, up 16.51% year-over-year. In the year 2024, Talanx AG had annual revenue of 41.40B with 8.11% growth.
Revenue (ttm)
45.27B EUR
Revenue Growth
+16.51%
P/S Ratio
0.63
Revenue / Employee
1.54M EUR
Employees
29,357
Market Cap
24.30B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 41.40B | 3.11B | 8.11% |
| Dec 31, 2023 | 38.29B | -1.61B | -4.03% |
| Dec 31, 2022 | 39.90B | -3.83B | -8.75% |
| Dec 31, 2021 | 43.73B | 4.39B | 11.15% |
| Dec 31, 2020 | 39.34B | 969.00M | 2.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 140.08B |
| Unilever | 51.24B |
| HSBC Holdings | 43.13B |
| AstraZeneca | 41.24B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.03B |